Growth Metrics

Elevance Health (ELV) Equity Average (2016 - 2025)

Historic Equity Average for Elevance Health (ELV) over the last 17 years, with Q4 2025 value amounting to $44.1 billion.

  • Elevance Health's Equity Average rose 328.59% to $44.1 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $44.1 billion, marking a year-over-year increase of 328.59%. This contributed to the annual value of $42.7 billion for FY2025, which is 571.69% up from last year.
  • Elevance Health's Equity Average amounted to $44.1 billion in Q4 2025, which was up 328.59% from $44.0 billion recorded in Q3 2025.
  • In the past 5 years, Elevance Health's Equity Average registered a high of $44.1 billion during Q4 2025, and its lowest value of $33.6 billion during Q1 2021.
  • Over the past 5 years, Elevance Health's median Equity Average value was $38.2 billion (recorded in 2023), while the average stood at $38.8 billion.
  • As far as peak fluctuations go, Elevance Health's Equity Average surged by 55.86% in 2022, and later surged by 1213.39% in 2024.
  • Quarter analysis of 5 years shows Elevance Health's Equity Average stood at $36.0 billion in 2021, then increased by 0.56% to $36.2 billion in 2022, then rose by 7.7% to $39.0 billion in 2023, then rose by 9.44% to $42.7 billion in 2024, then grew by 3.29% to $44.1 billion in 2025.
  • Its Equity Average was $44.1 billion in Q4 2025, compared to $44.0 billion in Q3 2025 and $43.2 billion in Q2 2025.